Nyumbani › Burkitt Lymphoma › Delaware
Majaribio ya kliniki ya Burkitt Lymphoma katika jimbo la Delaware
Masomo 7 ya Burkitt Lymphoma yanatafuta washiriki katika vituo vya jimbo la Delaware.
Maandishi rasmi ya utafiti (Kiingereza)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
InaajiriHatua 2
366 Days – 46 Years · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06124157Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT03739814Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Alfred I duPont Hospital for Children, Wilmington
InaajiriHatua 2
365 Days · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT06317662A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Alfred I duPont Hospital for Children, Wilmington
InaajiriHatua 2
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 1 Sep 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Alfred I duPont Hospital for Children, Wilmington
InaajiriHatua 3
365 Days – 25 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT03959085Study of SGR-1505 in Mature B-Cell Neoplasms
- Christiana Care Hospital - Helen F Graham Cancer Center, Newark
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Feb 2026 · NCT05544019The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington
InaajiriHatua 2
Umri 1 hadi 25 · Jinsia zote · Imesasishwa 4 Mei 2025 · NCT03509961Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.